Anesthetics and the developing brain

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 14, Issue 1, 2010, Pages 44-45

  Yudkowitz, Francine S ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Developing brain; Pediatrics

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROPOFOL; 4 AMINOBUTYRIC ACID;

APOPTOSIS; BRAIN DEVELOPMENT; COGNITIVE DEFECT; HUMAN; MEMORY DISORDER; NERVE CELL; NERVE DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY; SEDATION; SEIZURE; SHORT SURVEY; STRESS; ARTICLE; DISORDERS OF HIGHER CEREBRAL FUNCTION; LEARNING; MEMORY; SYNAPTOGENESIS;

ANESTHETICS; ANIMALS; APOPTOSIS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA AGONISTS; HUMANS; RECEPTORS, N-METHYL-D-ASPARTATE; SPECIES SPECIFICITY; SURGICAL PROCEDURES, OPERATIVE; TIME FACTORS;

EID: 77954888693     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1177/1089253210362791     Document Type: Short Survey

References (12)

1. Ikonomidou C., Bosch F., Miksa M., et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science, 1999; 283:70-74.
2. Ikonomidou C., Bittigau P., Koch C., et al. Neurotransmitters and apoptosis in the developing brain. Biochem Pharmacol. 2001 ; 62: 401-405. (Pubitemid 29044848).
3. Slikker W. Jr, Paule MG, Linnzi KM, et al. Systems biology approaches for toxicology. J Appl Toxicol. 2007 ; 27: 201-217.
4. Rice D., Barone S. Jr. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 2000 ; 108: 511-533.
5. Scallet AC, Schmued LC, Slikker W., et al. Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol Sci. 2004 ; 81: 364-370.
6. Young C., Jevtovic-Todorovic V., Qin Y-Q., et al. Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br J Pharmacol. 2005 ; 146: 189-197.
7. Cattano D., Young C., Straiko MMW, Olney JW Subanesthetic doses of propofol induce neuroapoptosis in the infant mouse brain. Anesth Analg. 2008 ; 106: 1712-1714.
8. Slikker W. Jr, Zou X., Hotchkiss CE, et al. Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol Sci. 2007 ; 98: 145-158.
9. Hayashi H., Dikkes P., Soriano SG Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr Anaesth. 2002 ; 12: 770-774.
10. Kanwaljeet JS, Anand SG, Rovnaghi CR, et al. Ketamine reduces the cell death following inflammatory pain in newborn rat brain. Pediatr Res. 2007 ; 62: 283-290.
11. Hermann C., Hohmeister J., Demirakca S., et al. Long-term alteration of pain sensitivity in school-aged children with early pain experiences. Pain. 2006 ; 125: 278-285.
12. Anand KJ, Sippell WG, Aynsley-Green A. Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. Lancet. 1987 ; 1 (8524). 62-66.